Radio Electric Asymmetric Conveyer (REAC) Biomodulation for Chronic Pain and Functional Improvement in Rheumatoid Arthritis, Lipedema, and Fibromyalgia: A Case Study on Anti-inflammatory, Circulatory, and Metabolic Optimization

Abstract

This case report explores the use of radio electric asymmetric conveyor (REAC) technology for chronic pain management, functional limitations, and metabolic dysfunction in a 67-year-old female with rheumatoid arthritis, advanced lipedema, and fibromyalgia. The patient underwent three REAC protocols: Anti-cellulite treatment (ACT), circulatory optimization (CO), and metabolic optimization (MO), each targeting distinct pathophysiological aspects. The ACT protocol primarily addressed chronic inflammation contributing to pain and tissue dysfunction associated with lipedema. The CO protocol enhanced joint mobility by improving systemic and local blood flow, relieving joint stiffness due to rheumatoid arthritis. The MO protocol focused on metabolic restoration to counter chronic fatigue linked to lipedema and fibromyalgia. SF-12 results showed a significant improvement in physical health index (50.88% to 68.16%) and mental health index (58.38% to 86.40%). Depression, anxiety and stress scale - 21 (DASS-21) scores indicated a decrease in the depression index (47.62% to 23.81%) and stress index (57.14% to 42.86%), with anxiety remaining stable at 23.81%. This case underscores REAC technology's potential as a non-invasive, multifaceted intervention addressing underlying inflammation, circulatory impairment, and metabolic dysregulation in complex chronic conditions, offering a valuable alternative to conventional treatments. Following treatment, the patient reported substantial reductions in pain and physical discomfort, increased mobility, and enhanced energy and emotional well-being. Improvements began after ACT, with decreased pain and increased ease in daily activities. CO further supported joint mobility, allowing tasks like walking and stair-climbing with less strain. MO led to greater overall vitality and mood stability, enabling a more active lifestyle. No significant adverse effects were reported. This case underscores REAC technology's potential as a non-invasive, multifaceted intervention addressing the underlying inflammation, circulatory impairment, and metabolic dysregulation in complex chronic conditions, offering a valuable alternative to conventional treatments. Further research could clarify REAC's broader applications in similar multifactorial cases.

Keywords: chronic pain management; rheumatoid arthritis.